Vaxcyte, Inc. PCVX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s retained earnings?
- Vaxcyte, Inc. (PCVX) reported retained earnings of -$2.48B in Q1 2026.
- How has Vaxcyte, Inc.'s retained earnings changed year-over-year?
- Vaxcyte, Inc.'s retained earnings decreased by 61.9% year-over-year, from -$1.53B to -$2.48B.
- What is the long-term trend for Vaxcyte, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s retained earnings has grown at a 61.1% compound annual growth rate (CAGR), from -$198.56M to -$2.15B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.